These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5355630)

  • 1. [CY 58 in treatment of acute ischemia of the extremities].
    Cassou JM; Henriet P; Vandecasteele J
    Lille Med; 1969 Apr; 14(4):Suppl 3:503-7. PubMed ID: 5355630
    [No Abstract]   [Full Text] [Related]  

  • 2. [CY 58 in the treatment of acute ischemia of the extremities].
    Cassou JM; Henriet P; Vandecasteele J
    Lille Med; 1969 Apr; 14():Suppl 3:503-7. PubMed ID: 5376444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic treatment of arterial embolism].
    Dorobisz T; Jaworski Z; Samplawska B; Skóra K; Szydlowski Z
    Pol Tyg Lek; 1969 Apr; 24(15):579-81. PubMed ID: 5801918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of thrombolytin in surgical clinical practice].
    Belorusov OS; Guseĭnov ChS; Izmaĭlova EF; Smirnova LA
    Vestn Khir Im I I Grek; 1968 Aug; 101(8):53-7. PubMed ID: 5705028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of plasminogen activator (urokinase) in treatment of hemorrhage and thromboembolism of the eye].
    Gastaldi GM; Diotti G
    Minerva Oftalmol; 1969; 11(3):82-9. PubMed ID: 5406013
    [No Abstract]   [Full Text] [Related]  

  • 6. [When is fibrinolytic therapy indicated?].
    Woitinas F
    Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
    [No Abstract]   [Full Text] [Related]  

  • 7. On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae.
    Ferliga G
    G Gerontol; 1966 Jun; 14(6):555-69. PubMed ID: 5989598
    [No Abstract]   [Full Text] [Related]  

  • 8. [The acute arterial occlusion of the extremities].
    Dost K
    Med Welt; 1969 May; 22():1275-81. PubMed ID: 5801046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of peripheral vascular disorders, including thromboembolism and hyperlipemia, using pentose polysulfonic ester].
    Szirmai E; Celander DR
    Angiologia; 1968; 20(2):79-83. PubMed ID: 5739416
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the management of retinal blood circulation disorders due to arteriosclerosis and their sequellae].
    Kager S
    Med Klin; 1967 Sep; 62(38):1466-7. PubMed ID: 5627988
    [No Abstract]   [Full Text] [Related]  

  • 11. Urokinase in pulmonary thromboembolic disease: a preliminary report.
    Dickie K; de Groot W
    Tex Rep Biol Med; 1967; 25(4):613-24. PubMed ID: 6082233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy in primary vascular pulmonary hypertension].
    Fischer M; Mösslacher H; Slany J
    Med Welt; 1971 Feb; 8():299-302. PubMed ID: 5552722
    [No Abstract]   [Full Text] [Related]  

  • 13. Selection of treatment in acute ischaemia.
    Swedenborg J
    Ann Chir Gynaecol; 1995; 84(4):354-7. PubMed ID: 8687079
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolysis in extremital arteries--indications and methods.
    Wellander E; Risberg B
    Ann Chir Gynaecol; 1995; 84(4):341-8. PubMed ID: 8687077
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboembolic disease and antithrombotic agents in the elderly. Preface.
    Jacobs LG
    Cardiol Clin; 2008 May; 26(2):xiii-xiv. PubMed ID: 18406990
    [No Abstract]   [Full Text] [Related]  

  • 16. Urokinase thrombolysis as initial therapy for acute and non-acute ischemic extremities.
    Byrne D; Byrne WD; Kiernan PD; Harshaw W; Bryne J; Fulcher T; Stanton L; Goodman S; Karnaze M
    Va Med Q; 1997; 124(1):41-4. PubMed ID: 9009854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations?
    Zakarija A; Bennett CL
    Arch Intern Med; 2005 Apr; 165(7):722-3. PubMed ID: 15824289
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of fibrinolytic drugs].
    Düzenli MA; Ozdemir K; Sökmen A; Karabağ T
    Anadolu Kardiyol Derg; 2003 Jun; 3(2):162-70. PubMed ID: 12826513
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of the sequential treatment with defibrinating agents and plasminogenic urokinase in thromboembolic disease].
    Charbonnier B; Griguer P; Brochier M; Monpère C; Raynaud P
    Agressologie; 1983 Nov; 24(11):587-90. PubMed ID: 6670690
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolytic treatment of cerebral thromboembolism].
    Castellano F; Ambrosio A; Profeta G
    Neurochirurgie; 1970; 16(1):81-8. PubMed ID: 5446716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.